Eosinophilia: all 52 studies
Page 1 of 1. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Stapokibart in Non-Allergic Rhinitis With Eosinophilia SyndromeNot yet recruitingNCT07240376Not applicable
- Specific Versus Empirical Anthelminthic Treatment in EosinophiliaRecruitingNCT06265870Not applicable
- Baricitinib Plus Glucocorticoid for Eosinophilia in IgG4-RDRecruitingNCT05781516Not applicable
- Study of Gastric Motility in Eosinophilic GastritisRecruitingNCT05229432
- Natural History of Hypereosinophilia and Hypereosinophilic SyndromesRecruitingNCT04018118
- Ketotifen for Children With Functional Dyspepsia in Association With Duodenal EosinophiliaRecruitingNCT02484248Phase 3
- Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic DisordersRecruitingNCT00267501
- A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease ProgressionRecruitingNCT00091871
- Activation and Function of Eosinophils in Conditions With Blood or Tissue EosinophiliaRecruitingNCT00001406
- Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic EsophagitisCompletedNCT04991935Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic EsophagitisCompletedNCT04753697Phase 3Results posted
- A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.TerminatedNCT04612790Phase 3Results posted
- Mepolizumab in Episodic Angioedema With EosinophiliaTerminatedNCT04128371Phase 2Results posted
- Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic TrialCompletedNCT04075331Phase 2/3Results posted
- A Proof-of-mechanism Study of Multiple, Oral Doses of Fevipiprant (QAW039) in COPD Patients With EosinophiliaTerminatedNCT03810183Phase 2Results posted
- Benralizumab Effect on Severe Chronic Rhinosinusitis With Eosinophilic PolyposisCompletedNCT03450083Phase 2Results posted
- A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203)CompletedNCT03011372Phase 2Results posted
- Effect of OC459 on the Response to Rhinovirus Challenge in AsthmaCompletedNCT02660489Phase 2Results posted
- Study of Dexpramipexole Chronic Sinusitis With Nasal Polyps and EosinophiliaCompletedNCT02217332Phase 2Results posted
- Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic SyndromeStatus unknownNCT02130882Phase 2/3Results posted
- Steroid Treatment for Hypereosinophilic SyndromeCompletedNCT01524536Phase 4Results posted
- Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic SyndromeTerminatedNCT00097370Phase 3Results posted
- Dupilumab in Type 2-Inflamed COPD Across the Full Spectrum of Airflow Limitation: An Italian Multicentre Retrospective Cohort StudyCompletedNCT07788092
- New Cases of EoE in Children in Poland.CompletedNCT07772388
- Association Between Disease Severity and Clinical, Histopathological, and Eosinophilic Markers in Patients With Bullous Pemphigoid (BP-EPIC)Active, not recruitingNCT07649486
- A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosinusitis With Nasal PolypsActive, not recruitingNCT05942222Phase 4
- 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)CompletedNCT05634746Phase 3
- Relationship Between Cardiovascular Disease in Asthma and Eosinophil Subtypes and Biomarkers of Bronchial Remodeling.Status unknownNCT05589779
- Expanded Access Protocol for Patients With Eosinophilic EsophagitisNo longer availableNCT05095116
- Efficacy and Safety APT-1011 in Adolescent Subjects With Eosinophilic Esophagitis (EoE) - A Sub-Study of the FLUTE-2 TrialCompletedNCT05083312Phase 3
- Drivers of Eosinophilic COPD ExacerbationsStatus unknownNCT04961060
- Gastrointestinal STRING Test With Oral ImmunotherapyTerminatedNCT04943744Early Phase 1
- Clinical Characteristics and Treatment of Chest Tightness Variant AsthmaStatus unknownNCT04322422Not applicable
- Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)CompletedNCT04281108Phase 3
- Home Air Purification for Eosinophilic COPDCompletedNCT04252235Not applicable
- Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE)Active, not recruitingNCT04149470Phase 4
- Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma.WithdrawnNCT03989635Phase 2
- Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic DisordersActive, not recruitingNCT03801434Phase 2
- Identifying Serum Cytokine Profiles of Distinct Inflammatory Phenotypes in Severe AsthmaCompletedNCT03563521
- Research for Angiostrongylus Cantonensis and Costaricensis in French West Indies and French GuianaStatus unknownNCT03378882
- Clinical Characteristics, Treatment and Prognosis of Chest Tightness Variant AsthmaCompletedNCT03237221
- Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Eosinophilia Among Primary Care PatientsCompletedNCT03018808
- Functional Dyspepsia (FD) - Clinical Response to Montelukast in ChildrenCompletedNCT02360696
- Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic SyndromeStatus unknownNCT02101138Phase 2
- Mepolizumab Treatment for Rhinovirus-induced Asthma ExacerbationsStatus unknownNCT01520051Phase 3
- Registry for Eosinophilic Gastrointestinal Disorders (REGID)CompletedNCT01382563
- Natural History of Severe Allergic Inflammation and ReactionsCompletedNCT01164241
- Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity IndexStatus unknownNCT00939263
- Treatment of Asymptomatic Toxocariasis With Albendazole in ChildrenActive, not recruitingNCT00755560Phase 3
- Phase II Gleevec Idiopathic Hypereosinophilic SyndromeTerminatedNCT00230334Phase 2
- Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)CompletedNCT00086658Phase 3
- Anti-Interleukin-5 Antibody to Treat Hypereosinophilic SyndromeCompletedNCT00017862Phase 2